SIM
SBBP

Spark Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Spark Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-32,800
Closed -$146K – 753
2018
Q4 		$146K Buy
+32,800
New +$160K 0.01% 530
2018
Q3 		– Sell
-28,900
Closed -$173K – 778
2018
Q2 		$173K Buy
28,900
+1,700
+6% +$12.4K 0.01% 571
2018
Q1 		$240K Buy
+27,200
New +$204K 0.02% 487
2017
Q2 		– Sell
-19,200
Closed -$91K – 906
2017
Q1 		$91K Buy
19,200
+2,400
+14% +$7.35K 0.01% 782
2016
Q4 		$40K Buy
+16,800
New +$68.5K ﹤0.01% 750

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Spark Investment Management's SBBP Position: Q1 2019 in Review

Spark Investment Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2019, closing a stake of 32,800 shares — an estimated $146K sold.

Spark Investment Management first reported a position in SBBP in Q4 2016 and held it in 5 quarters. The position peaked at $240K in Q1 2018. 51 funds tracked by Wall St. Rank hold SBBP as of Q1 2019.

  • Spark Investment Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 32,800 Strongbridge Biopharma plc. shares in Q1 2019, an estimated $146K.
  • Spark Investment Management first reported a position in Strongbridge Biopharma plc. in Q4 2016 and held it in 5 quarters.
  • Spark Investment Management's Strongbridge Biopharma plc. position peaked at $240K in Q1 2018.
  • 51 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.